We have located links that may give you full text access.
Journal Article
Review
Determinants of MRSA prevalence in the Asia Pacific Region: a systematic review and meta-analysis.
Journal of Global Antimicrobial Resistance 2018 August 24
OBJECTIVE: We aimed to review published literature on methicillin resistant S. aureus (MRSA) in the Asia Pacific Region to document MRSA prevalence in the Region and examine the impact of variability in study design on the reported data of MRSA prevalence.
METHODS: We included studies that reported MRSA prevalence between 2000 and 2016 and excluded studies if they did not contain complete information on antibiotic susceptibility testing (AST) methods Our primary outcomes were the proportion of MRSA isolates among S. aureus isolates (resistance proportion) or among individual samples (prevalence).
FINDINGS: We included 229 studies in 19 countries/territories in this study. There was substantial heterogeneity in both outcomes (resistance proportion: I2 =99·6%, prevalence: I2 =99·8%), precluding pooled averages, and meta-regression analyses revealed that these variations were explained by country income status and participant characteristics but not methodological differences in AST. We also found no significant secular changes in MRSA prevalence or resistance proportions in the Asia Pacific.
CONCLUSION: The resistance proportions and prevalence of MRSA infections in the Asia Pacific is comparable to those reported in other regions with no significant secular changes in the past decade. Country income status and the characteristics of the sample population explained more variations in the reported resistance proportions and prevalence of MRSA than methodological differences in AST across locations in the Region.
METHODS: We included studies that reported MRSA prevalence between 2000 and 2016 and excluded studies if they did not contain complete information on antibiotic susceptibility testing (AST) methods Our primary outcomes were the proportion of MRSA isolates among S. aureus isolates (resistance proportion) or among individual samples (prevalence).
FINDINGS: We included 229 studies in 19 countries/territories in this study. There was substantial heterogeneity in both outcomes (resistance proportion: I2 =99·6%, prevalence: I2 =99·8%), precluding pooled averages, and meta-regression analyses revealed that these variations were explained by country income status and participant characteristics but not methodological differences in AST. We also found no significant secular changes in MRSA prevalence or resistance proportions in the Asia Pacific.
CONCLUSION: The resistance proportions and prevalence of MRSA infections in the Asia Pacific is comparable to those reported in other regions with no significant secular changes in the past decade. Country income status and the characteristics of the sample population explained more variations in the reported resistance proportions and prevalence of MRSA than methodological differences in AST across locations in the Region.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app